Krystal Biotech, Inc. - 8-K Filing
Krystal Biotech filed a patent response with data from one patient showing complete corneal defect closure in KB801 gene therapy trial (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $KRYS